Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study

• Main Authors: Ooi, Choon Jin, Hilmi, Ida Normiha, Kim, Hyo-Jong, Jalihal, Umesh, Wu, Deng-Chyang, Demuth, Dirk, Lindner, Dirk, Adsul, Shashi
• Format: Article
• Published: Korean Assoc Study Intestinal Diseases 2021
• Subjects: R Medicine (General)
• Online Access: http://eprints.um.edu.my/34990/

Background/Aims: The efficacy and safety of vedolizumab in moderate to severely active ulcerative colitis (UC) have been demonstrated in the GEMINI 1 study (NCT00783718). This post-hoc exploratory analysis sought to establish the efficacy and safety of vedolizumab in a subgroup of patients from Asia...